Jardiance 25 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F7ZYM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,376
Award facts
- Contract value 100% obligated
- $24,376.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24.4K firm fixed-price delivery order to AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., on January 31, 2026, for the supply of 90-count bottles of Jardiance 25 mg tablets, with completion expected by February 2, 2026. The delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This represents a small-value task order supporting the federal government's pharmaceutical supply needs for military healthcare systems.
This delivery order is issued under AmerSourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.9M through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The parent company, Cencora, Inc., holds an even larger IDC with the Defense Logistics Agency valued at up to $999.9M through December 31, 2031, establishing AmerSourceBergen as a critical supplier of prescription medications, specialty pharmaceuticals, vaccines, and medical supplies to support military treatment facilities and veteran healthcare programs worldwide. Jardiance, an antidiabetic medication, aligns with the contractor's demonstrated portfolio of delivering diabetes and specialty medications across multiple therapeutic domains to federal healthcare customers.
Quick answers
Who was awarded contract SPE2DR26F7ZYM?
SPE2DR26F7ZYM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 31, 2026.
How much is contract SPE2DR26F7ZYM worth?
The government has obligated $24,376 on SPE2DR26F7ZYM.
Is contract SPE2DR26F7ZYM an order under another contract?
Yes. SPE2DR26F7ZYM is a delivery order under SPE2DR25D7066, an indefinite delivery contract.
Was contract SPE2DR26F7ZYM competed?
The extent of competition for SPE2DR26F7ZYM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award